Defective de novo methylation of viral and cellular DNA sequences in ICF syndrome cells
description
Transcript of Defective de novo methylation of viral and cellular DNA sequences in ICF syndrome cells
Defective de novo methylation of viral and cellular DNA sequences in
ICF syndrome cells
Robertson K. et al.
Human Molecular Genetics, 2002
Gergana UgrinovaUniversity of Notre Dame October 11, 2002
2
Overview
• Background
• Experiments and results
• Conclusions
• Questions
3
DNA methylation
• covalent modification at 5' position of the cytosine ring
• occurs predominantly within the context of CpG dinucleotide
Molecular Biology of the Cell. 3rd ed., Alberts, B. et al.
4
CpG distribution
• Majority of mammalian genome is very CG poor• 5'-promoter regions of all housekeeping genes and
some tissue-specific genes contain clusters of CpG dinucleotides, termed CpG islands
• Most parasitic and repetitive DNA sequences (satellite DNA) are very rich in CpG dinucleotides
5
Enzymes
Robertson K., Oncogene, 2002
6
Enzymes
• Three catalytically active methyltransferases
– DNMT1 - maintenance methyltransferase• localizes to DNA replication foci
– DNMT3A and DNMT3B - de novo methyltransferases• highly active in ES cells and early embryos
7
Role of DNA methylation
• Embryonic development• X chromosome inactivation in females• Genomic imprinting• Chromatin remodeling• Tumorigenesis
8
ICF syndrome
• rare autosomal recessive disease• defect in DNMT3B gene
• Immune deficiency• Centromere instability• Facial anomalies
9
ICF syndrome phenotype
• At the cytogenetic level – anomalous chromosome decondensation
– centromeric breakage
– multiradial chromosomes
– hypomethylation of the juxtacentromeric repeat sequences on chromosomes 1, 9 and 16
10
What is known up to now?
• BGS revealed a 50% decrease in methylation of satellite 2 repeats (on chromosomes 1 and 16)
• The overall reduction in cellular 5-methylcytosine levels was about 7%
• A number of genes on the inactive X chromosome have been found to be hypomethylated in ICF cells
• Genes whose expression was aberrantly up- or down-regulated in ICF do not have detectable methylation changes
11
Objectives:
• To gain a better understanding of the types of DNA sequences, whose methylation is established and/or maintained by DNMT3B
12
Approach
• Analysis of number of viral and cellular genes in 2 EBV-established well-characterized ICF cell lines
Mutation in DNMT3B
ICF 1 Male homozygous V726G
ICF 2 Female heterozygous A603T
intron 22 G-A insertion of STP
Cell line
13
Advantages of EBV-based system
• EBV minichromosome is completely sequenced and gene expression patterns upon infection have been extensively studied
• methylation status is well characterized and it is known that it undergoes defined de novo methylation events during the establishment of LCLs in vitro
14
Methods
• Bisulfite genomic sequencing
• Methylation specific PCR
• Semiquantative RT-PCR
15
Bisulfite genomic sequencing
• Bisulfite treatment of DNA - convert unmethylated cytosine to uracil
• PCR with strand specific primers • cloning of PCR products• sequencing of the cloned PCR products
16
Methylation specific PCR
• Bisulfite treatment of DNA - convert unmethylated cytosine to uracil
• PCR with methylation specific primers– primers for methylated C (C-G)
– primers for unmethylated C (U-A)
• Agarose gel electrophoresis of the resulting PCR products
17
EBV genome
Tao Q., Huang H., Geiman T., Yen Lim C., Fu L., Qiu G. and Robertson K., Hum. Mol. Genetics, 2002
18
MSP analysis of Cp and Wp
Wp - normally undergoes de novo methylation
19
Expression from Cp and Wp
20
EBV genome
21
BGS analysis of Rp
22
Semiquantative RT-PCR of Zp and Rp
23
RT-PCR analysis of BHRF1 and BLLF1
24
Summary of analysis of EBV regions
• All promoters subject to de novo methylation in normal LCLs are highly hypomethylated in ICF cells
• What about cellular genes?
25
Scheme of the MAGE-A1 and LAGE-1/2 cellular gene promoters
26
BGS analysis of MAGE-A1 and LAGE-1/2
27
Quantification of BGS data
28
Expression from MAGE-A1 and LAGE-1/2
29
Summary of the analysis of C-T cellular genes
• MAGE-A1 CpG island promoter was heavily methylated in all cell line and expression of the gene was not detectable
• LAGE-1/2 CpG island promoter was heavily methylated in ICF 1 and normal cells
• LAGE-1/2 in ICF 2 cell line showed 2 fold decrease in methylation and the gene LAGE-1 was detected by RT-PCR
30
Schematic of SCP-1 gene promoter
31
MSP methylation analysis of ICF and normal LCLs for SCP-1
32
SCP-1 expression monitored by RT-PCR
33
Expression of DNA methyltransferases in ICF cells
34
Conclusions
• These studies provide first direct evidence for defective de novo methylation in ICF cells
• C-T gene family may represent a new class of genes that are reliant on DNMT3B for proper de novo methylation
• Utility of EBV-based system for examining the complex and poorly understood process of de novo methylation
35
Questions
• How the specific mutation in DNMT3B gene plays a role in severity of the phenotype?
• Are the interactions between DNM3B and other DNA-binding proteins (HDACs, chromatin remodeling proteins) impaired and if yes -in what way?
• Have all of the DNA methylating activities in mammalian cells been defined?
36
Thank you!
37
References:
1. Tao Q., Huang H., Geiman T., Yen Lim C., Fu L., Qiu G and Robertson K., Hum. Mol. Genetics, 2002, 11, 18, 2091-2102
2. Okano M. et al., Cell,1999, 99, 245-257
3. Robertson K. et al., Nucleic Acids Research, 1999, 27, 11, 2291-2298
4. Robertson K., Oncogene, 2002, 21, 5361-5379
5. Tao Q. et al.. American Journal of Pathology, 1999, 155, 2, 619-625
6. Frommer M. et al., PNAS, 1992, 89, 1827-1831
7. Herman et al., PNAS, 1996, 93. 9821-9826
8. Scott Hansen R. et al., PNAS, 1999, 96, 25, 14412-14417